ImmunoGen, Inc.

BNP PARIBAS FINANCIAL MARKETS

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

137,098

Value ($000)

4,065

Weight

0.0%

2014 Q1 - 2023 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	4,065	0.0%	137,098	12/31/2023
2023 Q3	11/14/2023	3,747	0.0%	236,082	9/30/2023
2023 Q2	8/9/2023	7,142	0.0%	378,491	6/30/2023
2023 Q1	5/12/2023	2,065	0.0%	537,702	3/31/2023
2022 Q4	2/14/2023	1,803	0.0%	363,564	12/31/2022
2022 Q3	11/16/2022	1,645	0.0%	344,240	9/30/2022
2022 Q2	8/12/2022	281	0.0%	62,424	6/30/2022
2022 Q1	5/18/2022	150	0.0%	31,443	3/31/2022
2021 Q4	2/9/2022	457	0.0%	61,561	12/31/2021
2021 Q3	11/16/2021	335	0.0%	59,155	9/30/2021
2021 Q2	8/10/2021	172	0.0%	26,150	6/30/2021
2021 Q1	5/7/2021	635	0.0%	78,396	3/31/2021
2020 Q4	2/10/2021	146	0.0%	22,592	12/31/2020
2020 Q3	10/30/2020	146	0.0%	40,451	9/30/2020
2020 Q2	8/6/2020	94	0.0%	20,396	6/30/2020
2020 Q1	5/13/2020	271	0.0%	79,422	3/31/2020
2019 Q4	2/12/2020	117	0.0%	22,894	12/31/2019
2014 Q1	5/13/2014	1	0.0%	41	3/31/2014